Literature DB >> 19147075

Plasma biomarkers in graft-versus-host disease: a new era?

Sophie Paczesny1, John E Levine, Thomas M Braun, James L M Ferrara.   

Abstract

Acute graft versus host disease (GVHD) remains a major complication of allogeneic hematopoietic cell transplantation (HCT). The diagnosis of acute GVHD is based on strictly clinical criteria and its severity also determined by these criteria. Currently, there is no validated diagnostic blood test for acute GVHD. This review will summarize proteomics approaches to identify biomarkers for GVHD in the plasma with diagnostic, prognostic and predictive value. If successful, these studies could establish a novel biomarker panel that will contribute important information including long term survival, and that may eventually facilitate therapeutic decisions for allogeneic HCT patients.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19147075      PMCID： PMC2644447          DOI： 10.1016/j.bbmt.2008.10.027

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


  32 in total

1.  Serum levels of soluble IL-2 receptor, IL-12, IL-18, and IFN-gamma in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation.

Authors:  H Nakamura; K Komatsu; M Ayaki; S Kawamoto; M Murakami; N Uoshima; T Yagi; T Hasegawa; M Yasumi; T Karasuno; H Teshima; A Hiraoka; T Masaoka
Journal:  J Allergy Clin Immunol       Date:  2000-07       Impact factor: 10.793

2.  Serum tumor necrosis factor alpha associated with acute graft-versus-host disease in humans.

Authors:  F W Symington; M S Pepe; A B Chen; A Deliganis
Journal:  Transplantation       Date:  1990-09       Impact factor: 4.939

3.  Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation.

Authors:  E Holler; H J Kolb; A Möller; J Kempeni; S Liesenfeld; H Pechumer; W Lehmacher; G Ruckdeschel; B Gleixner; C Riedner
Journal:  Blood       Date:  1990-02-15       Impact factor: 22.113

4.  Increased hepatocyte growth factor in serum in acute graft-versus-host disease.

Authors:  T Okamoto; H Takatsuka; Y Fujimori; H Wada; T Iwasaki; E Kakishita
Journal:  Bone Marrow Transplant       Date:  2001-07       Impact factor: 5.483

5.  Elevated interleukin (IL)-18 levels during acute graft-versus-host disease after allogeneic bone marrow transplantation.

Authors:  Y Fujimori; H Takatsuka; Y Takemoto; H Hara; H Okamura; K Nakanishi; E Kakishita
Journal:  Br J Haematol       Date:  2000-06       Impact factor: 6.998

6.  Increased levels of syndecan-1 in serum during acute graft-versus-host disease.

Authors:  Carina Seidel; Olle Ringdén; Mats Remberger
Journal:  Transplantation       Date:  2003-07-27       Impact factor: 4.939

7.  Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation.

Authors:  Thorsten Kaiser; Haytham Kamal; Andreas Rank; Hans-Jochem Kolb; Ernst Holler; Arnold Ganser; Bernd Hertenstein; Harald Mischak; Eva Maria Weissinger
Journal:  Blood       Date:  2004-03-30       Impact factor: 22.113

8.  Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation.

Authors:  R Schots; L Kaufman; I Van Riet; T Ben Othman; M De Waele; B Van Camp; C Demanet
Journal:  Leukemia       Date:  2003-06       Impact factor: 11.528

9.  A biomarker panel for acute graft-versus-host disease.

Authors:  Sophie Paczesny; Oleg I Krijanovski; Thomas M Braun; Sung W Choi; Shawn G Clouthier; Rork Kuick; David E Misek; Kenneth R Cooke; Carrie L Kitko; Angela Weyand; Daniel Bickley; Dawn Jones; Joel Whitfield; Pavan Reddy; John E Levine; Samir M Hanash; James L M Ferrara
Journal:  Blood       Date:  2008-10-02       Impact factor: 22.113

10.  Serum cytokine levels and acute graft-versus-host disease after HLA-identical hematopoietic stem cell transplantation.

Authors:  Jeane Eliete Laguila Visentainer; Sofia Rocha Lieber; Lígia Beatriz Lopes Persoli; Afonso Celso Vigorito; Francisco José Penteado Aranha; Kátia Aparecida de Brito Eid; Gislaine Borba Oliveira; Eliana Cristina Martins Miranda; Cármino Antonio de Souza
Journal:  Exp Hematol       Date:  2003-11       Impact factor: 3.084
View more
  19 in total

1.  Kinetics of lymphocyte reconstitution after allogeneic bone marrow transplantation: markers of graft-versus-host disease.

Authors:  Severin Zinöcker; Lisbet Sviland; Ralf Dressel; Bent Rolstad
Journal:  J Leukoc Biol       Date:  2011-04-15       Impact factor: 4.962

2.  Progress in mining the human proteome for disease applications.

Authors:  Sam Hanash
Journal:  OMICS       Date:  2011-03

Review 3.  Pathogenesis and management of graft-versus-host disease.

Authors:  Sung W Choi; John E Levine; James L M Ferrara
Journal:  Immunol Allergy Clin North Am       Date:  2010-02       Impact factor: 3.479

Review 4.  Mesenchymal stromal cells: a new tool against graft-versus-host disease?

Authors:  Frédéric Baron; Rainer Storb
Journal:  Biol Blood Marrow Transplant       Date:  2011-09-29       Impact factor: 5.742

5.  Endothelial damage is aggravated in acute GvHD and could predict its development.

Authors:  E Mir; M Palomo; M Rovira; A Pereira; G Escolar; O Penack; E Holler; E Carreras; M Diaz-Ricart
Journal:  Bone Marrow Transplant       Date:  2017-06-26       Impact factor: 5.483

6.  A molecular and computational diagnostic approach identifies FOXP3, ICOS, CD52 and CASP1 as the most informative biomarkers in acute graft-versus-host disease.

Authors:  Maria Cuzzola; Maurizio Fiasché; Pasquale Iacopino; Giuseppe Messina; Massimo Martino; Giuseppe Console; Roberta Fedele; Daniela Massi; Anna Grazia Recchia; Giuseppe Irrera; Fortunato Morabito
Journal:  Haematologica       Date:  2012-04-04       Impact factor: 9.941

7.  Identification of gene microarray expression profiles in patients with chronic graft-versus-host disease following allogeneic hematopoietic cell transplantation.

Authors:  Holbrook E Kohrt; Lu Tian; Li Li; Ash A Alizadeh; Sue Hsieh; Robert J Tibshirani; Samuel Strober; Minnie Sarwal; Robert Lowsky
Journal:  Clin Immunol       Date:  2013-05-01       Impact factor: 3.969

8.  Cellular immune function monitoring after allogeneic haematopoietic cell transplantation: evaluation of a new assay.

Authors:  M Israeli; T Klein; C Herscovici; R Ram; O Shpilberg; B Sredni; M Yeshurun
Journal:  Clin Exp Immunol       Date:  2013-06       Impact factor: 4.330

Review 9.  Acute graft-versus-host disease: new treatment strategies.

Authors:  Sophie Paczesny; Sung W Choi; James L M Ferrara
Journal:  Curr Opin Hematol       Date:  2009-11       Impact factor: 3.284

Review 10.  Translational opportunities for targeting the Th17 axis in acute graft-vs.-host disease.

Authors:  F Malard; B Gaugler; B Lamarthee; M Mohty
Journal:  Mucosal Immunol       Date:  2016-01-27       Impact factor: 7.313
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.